These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30410606)

  • 1. Cause-specific mortality prediction model for patients with basaloid squamous cell carcinomas of the head and neck: a competing risk analysis.
    Shen W; Sakamoto N; Yang L
    J Cancer; 2018; 9(21):4009-4017. PubMed ID: 30410606
    [No Abstract]   [Full Text] [Related]  

  • 2. Model to Predict Cause-Specific Mortality in Patients with Head and Neck Adenoid Cystic Carcinoma: A Competing Risk Analysis.
    Shen W; Sakamoto N; Yang L
    Ann Surg Oncol; 2017 Aug; 24(8):2129-2136. PubMed ID: 28424937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.
    Zhou H; Zhang Y; Qiu Z; Chen G; Hong S; Chen X; Zhang Z; Huang Y; Zhang L
    Clin Lung Cancer; 2018 Mar; 19(2):e195-e203. PubMed ID: 29153966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Competing-Risks Nomogram in Patients with Metastatic Pancreatic Duct Adenocarcinoma.
    Lu Y; Zhou Y; Cao Y; Shi Z; Meng Q
    Med Sci Monit; 2019 May; 25():3683-3691. PubMed ID: 31102397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis.
    Shen W; Sakamoto N; Yang L
    BMC Cancer; 2016 Jul; 16():413. PubMed ID: 27389173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model to predict cause-specific mortality in patients with olfactory neuroblastoma: a competing risk analysis.
    Liu L; Zhong Q; Zhao T; Chen D; Xu Y; Li G
    Radiat Oncol; 2021 Jun; 16(1):103. PubMed ID: 34112184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma.
    Wu X; Yu W; Petersen RH; Sheng H; Wang Y; Lv W; Hu J
    BMC Cancer; 2020 May; 20(1):429. PubMed ID: 32416716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomogram to predict cause-specific mortality of patients with rectal adenocarcinoma undergoing surgery: a competing risk analysis.
    Zhang X; Xu F; Bin Y; Liu T; Li Z; Guo D; Li Y; Huang Q; Lyu J; He S
    BMC Gastroenterol; 2022 Feb; 22(1):57. PubMed ID: 35144545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomograms for Estimating Cause-Specific Death Rates of Patients With Inflammatory Breast Cancer: A Competing-Risks Analysis.
    Xu F; Yang J; Han D; Huang Q; Li C; Zheng S; Wang H; Lyu J
    Technol Cancer Res Treat; 2021; 20():15330338211016371. PubMed ID: 34013802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis.
    Shen W; Sakamoto N; Yang L
    Ann Surg Oncol; 2015 Jan; 22(1):264-71. PubMed ID: 25074664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomogram predicting cancer-specific mortality in early-onset rectal cancer: a competing risk analysis.
    Wang Y; Wu J; He H; Ma H; Hu L; Wen J; Lyu J
    Int J Colorectal Dis; 2020 May; 35(5):795-804. PubMed ID: 32078716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Outcomes in the Patients With Colorectal Cancer: A Multi-Registry-Based Cohort Study of 197,699 Cases in the Real World.
    Zhang S; Wang Y; Zhang P; Ai L; Liu T
    Front Cardiovasc Med; 2022; 9():851833. PubMed ID: 35783821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basaloid squamous cell carcinoma of the head and neck: location means everything.
    Fritsch VA; Lentsch EJ
    J Surg Oncol; 2014 May; 109(6):616-22. PubMed ID: 24464879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A competing-risks nomogram and recursive partitioning analysis for cause-specific mortality in patients with esophageal neuroendocrine carcinoma.
    Zhang G; Wu B; Wang X; Li J
    Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30715226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basaloid squamous cell carcinoma of the hypopharynx: an analysis of 213 cases.
    Xie C; Liao J; Huang C; Wei F; Liu T; Wen W; Sun W
    Eur Arch Otorhinolaryngol; 2022 Apr; 279(4):2099-2107. PubMed ID: 34319483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck: a case-control study.
    Thariat J; Ahamad A; El-Naggar AK; Williams MD; Holsinger FC; Glisson BS; Allen PK; Morrison WH; Weber RS; Ang KK; Garden AS
    Cancer; 2008 Jun; 112(12):2698-709. PubMed ID: 18429002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of competing risk model in the prognostic prediction study of patients with follicular thyroid carcinoma.
    Wang Z; Mo C; Chen L; Kong L; Wu K; Zhu Y; Chen X
    Updates Surg; 2022 Apr; 74(2):735-746. PubMed ID: 34086182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomogram for Predicting Breast Cancer-Specific Mortality of Elderly Women with Breast Cancer.
    Lu X; Li X; Ling H; Gong Y; Guo L; He M; Sun H; Hu X
    Med Sci Monit; 2020 Sep; 26():e925210. PubMed ID: 32920589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in patients with gastric adenocarcinoma using competing-risk analysis: a study of cases in the SEER database.
    Zhang X; Yang J; Huang Q; Lyu J
    Scand J Gastroenterol; 2019 Aug; 54(8):1015-1021. PubMed ID: 31382800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.